Add News     Print  
Article List
Prevalence of diabetes in Kuwait ‘expected’ to rise Sanofi, Kuwait Diabetes Society to host specialists

KUWAIT CITY, April 11, (Agencies): In an effort to control the growing prevalence of diabetes in Kuwait, Sanofi, a diversified healthcare leader, have partnered with the Kuwait Diabetes Society to host sessions with medical professionals to discuss the best use of insulin in the treatment of type 2 diabetes. The current reported prevalence of diabetes in Kuwait remains at 17.9 percent, however a recent national survey indicates that the estimated growth of diabetes are expected to increase, if modifiable risk factors remain unchanged.

The survey interviewed Kuwaiti nationals between the ages of 20 and 65, and was conducted to determine the contributing factors that impact diabetes and subsequently the high rate of cardiovascular diseases in Kuwait. Professor Dr Geremia B. Bolli, world-renowned diabetes specialist and member of the European Association for the Study of Diabetes and American Diabetes Association, co-hosted sessions with Dr Monira Al Arouj, founding member and secretary general of the Kuwait Diabetes Society, to present best use of treatment options to general physicians and internal medicine specialists. Dr Al Arouj, the lead researcher for the national survey, said, “Our survey shows that there has been little change when it comes to modifiable risk factors of diabetes, which indicate that the situation is not getting better. Tackling diabetes in Kuwait requires the combined efforts of associations, medical professionals and patients to make the changes needed to curb the condition. Kuwait currently has the highest growing prevalence among the Arab countries and action is required to reduce this burden.”

The survey also showed that 62 percent of the participants lead sedentary lifestyles and approximately 18 percent were smokers. “Behavioural change among the public is crucial. However, as medical professionals, we need to make sure we understand the root causes and ensure we are up-to-date with the best medical therapies and treatments available to patients.

The doctor-patient relationship is vital to putting the country’s health back on track,” she added. Sanofi, who is an active participant in the country’s initiatives to tackle diabetes, firmly supports the continuous education of the medical community to further strengthen the doctor-patient relationship. “Diabetes is a global concern and sharing best practices and insights within the community can help medical professionals offer the best support available to patients.

By hosting these sessions, we believe that we can support the patient’s first line of defence — their physician. We have been working with the Kuwait Diabetes Society to pool our resources together to address the medical needs of the country,” said Ayman Mokthar, General Manager for Sanofi Gulf. Kuwait is the first Gulf country who hosted Dr Bolli, who will then travel to the UAE to meet with medical professionals to discuss the development of diabetes therapies and action needed to control the region’s health concerns.

Read By: 4553
Comments: 0

You must login to add comments ...
About Us   |   RSS   |   Contact Us   |   Feedback   |   Advertise With Us